GlassScriptPrepare for your visit
Shaun Chandna
Transplant Hepatology · Salt Lake City, UT · NPI 1497989719
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$52,314.11
in general payments reported to CMS, 2019-2025 · $48K in 2025
The $48K reported for 2025 was more than what 91% of Transplant Hepatology providers received nationally (typical 2025 total: $508).
Who reported paying
General payments only, top 6 by amount.
- Madrigal Pharmaceuticals $37,352.95
- Mirum Pharmaceuticals, INC. $8,795.29
- Ipsen Biopharmaceuticals, INC $3,286.00
- Gilead Sciences, INC. $751.68
- Intercept Pharmaceuticals, INC. $541.25
- Boston Scientific Corporation $286.96
Drugs and devices associated with these payments
Rezdiffra Livmarli Iqirvo Resmetirom Azur Cx Detachable Therasphere Y90 Glass Microspheres 10 Gbq Givlaari Navicross Ocaliva Xifaxan Lenvima Visiglide
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Shaun Chandna listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/662349/shaun-chandna